Skip to main content
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1985 Nov;143(5):672–675.

Acquired heparinlike anticoagulant in a patient with metastatic breast carcinoma.

G M Rodgers, L Corash
PMCID: PMC1306453  PMID: 4082574

Full text

PDF
672

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bussel J. B., Steinherz P. G., Miller D. R., Hilgartner M. W. A heparin-like anticoagulant in an 8-month-old boy with acute monoblastic leukemia. Am J Hematol. 1984 Jan;16(1):83–90. doi: 10.1002/ajh.2830160111. [DOI] [PubMed] [Google Scholar]
  2. Feinstein D. I., Rapaport S. I. Acquired inhibitors of blood coagulation. Prog Hemost Thromb. 1972;1:75–95. [PubMed] [Google Scholar]
  3. Gralnick H. R., Givelber H., Abrams E. Dysfibrinogenemia associated with hepatoma. Increased carbohydrate content of the fibrinogen molecule. N Engl J Med. 1978 Aug 3;299(5):221–226. doi: 10.1056/NEJM197808032990503. [DOI] [PubMed] [Google Scholar]
  4. Horner A. A. Electrophoresis of acidic mucopolysaccharides in agarose gel. Can J Biochem. 1967 Jul;45(7):1009–1013. doi: 10.1139/o67-116. [DOI] [PubMed] [Google Scholar]
  5. Khoory M. S., Nesheim M. E., Bowie E. J., Mann K. G. Circulating heparan sulfate proteoglycan anticoagulant from a patient with a plasma cell disorder. J Clin Invest. 1980 Mar;65(3):666–674. doi: 10.1172/JCI109712. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Muller A. D., van Doorm J. M., Hemker H. C. Heparin-like inhibitor of blood coagulation in normal newborn. Nature. 1977 Jun 16;267(5612):616–617. doi: 10.1038/267616a0. [DOI] [PubMed] [Google Scholar]
  7. Newburger P. E., Novak T. J., McCaffrey R. P. Eosinophilic cytoplasmic inclusions in fetal leukocytes: are Auer bodies a recapitulation of fetal morphology? Blood. 1983 Mar;61(3):593–595. [PubMed] [Google Scholar]
  8. Palmer R. N., Rick M. E., Rick P. D., Zeller J. A., Gralnick H. R. Circulating heparan sulfate anticoagulant in a patient with a fatal bleeding disorder. N Engl J Med. 1984 Jun 28;310(26):1696–1699. doi: 10.1056/NEJM198406283102603. [DOI] [PubMed] [Google Scholar]
  9. Schleider M. A., Nachman R. L., Jaffe E. A., Coleman M. A clinical study of the lupus anticoagulant. Blood. 1976 Oct;48(4):499–509. [PubMed] [Google Scholar]
  10. Teien A. N., Abildgaard U., Hök M. The anticoagulant effect of heparan sulfate and dermatan sulfate. Thromb Res. 1976 Jun;8(6):859–867. doi: 10.1016/0049-3848(76)90014-1. [DOI] [PubMed] [Google Scholar]
  11. Wight T. N. Vessel proteoglycans and thrombogenesis. Prog Hemost Thromb. 1980;5:1–39. [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES